Skip to content

Clinical trials

Phase 3 Osteoporosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Phase: Phase 3 Country / region: United States Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20016
20027
20039
20046
20055
20062
20074
20084
20093
20101
20111
20123
20141
20161
20183
20192
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62
Terminated4
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Amgen5
Radius Health, Inc.5
Shire4
Alliance for Clinical Trials in Oncology3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Pfizer3
Brigham and Women's Hospital2
Columbia University2
Eli Lilly and Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis68
Bone Diseases, Metabolic23
Osteoporosis, Postmenopausal10
Fractures, Bone8
Prostatic Neoplasms6
Breast Neoplasms4
Back Pain2
Bone Diseases2
Musculoskeletal Diseases2
Osteoporotic Fractures2

Trials

Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.